Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical

April 3, 1997

New experimental data on Asahi Chemical's ART-123

April 3, 1997

Corvas begins phase Ia trial of rNAPc2

April 3, 1997

Menarini prepares thrombin inhibitors

April 3, 1997

New thrombin inhibitors from Novartis

April 3, 1997

VIMRx licenses factor IXa inhibitor from Columbia University

April 2, 1997

First generic warfarin product cleared by the FDA

April 1, 1997

Genzyme Transgenics receives further funding for development of transgenic ATIII

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...